Search

everythinglearnresearchcommunity

for

Search:↓

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.

Higher DHT levels are linked to fewer hypogonadism symptoms in men with normal testosterone levels.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

More men are getting benign prostatic hyperplasia, and there are many treatments, from medication to surgery, with new methods being developed.

Dihydrotestosterone (DHT) mainly affects nearby cells, doesn't significantly change prostate hormonal environment or cancer risk, and doesn't play a main role in causing hair loss or acne. More research is needed on its effects on heart health, sexual function, and bone health.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

Finasteride caused enlarged breast tissue in a 62-year-old man.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Dihydrotestosterone treatment can help penis growth in boys with 5α-reductase deficiency but doesn't fully normalize size after puberty.

A mix of Panax ginseng and bee-pollen may help prevent prostate enlargement in rats.

The new oral testosterone pill normalized testosterone levels and lowered SHBG in men with low testosterone.

Common latent viruses might contribute to male-pattern baldness by disrupting cell processes that normally suppress hair loss-related proteins.

Testosterone and dihydrotestosterone treatments can help with penile growth in males with 5α-reductase type 2 deficiency, with dihydrotestosterone being more effective in infancy.

Androgen treatment with dihydrotestosterone may help maintain height in patients with 5-α-reductase type 2 deficiency, especially before puberty.

Dutasteride is more efficient than finasteride, but individual results vary.

Lovastatin doesn't improve lower urinary tract symptoms treatment.

Finasteride doesn't affect antipyrine metabolism, so interactions with cytochrome P-450 enzyme drugs are unlikely.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

Short-term finasteride treatment may lower some cell death factors in prostate cancer cells.

Finasteride helps treat prostate issues and may prevent prostate cancer in high-risk men.

Finasteride reduces prostate cancer risk but may increase high-grade cancer chances.

Oral finasteride and dutasteride may negatively affect erectile function in rats.

Cernitin™, a pollen extract, was found to significantly reduce pain and inflammation in rats with chronic prostatitis, suggesting it could be a useful alternative to certain anti-inflammatory drugs.

Finasteride doesn't harm male fertility or sperm quality, but may slightly reduce ejaculate volume.

Some plant-based treatments can help with benign prostatic hyperplasia symptoms, but more research is needed to confirm their safety and effectiveness.

Using finasteride or dutasteride may cause long-lasting erectile dysfunction.

The protein StAR is found in 17 different organs and can affect hair loss and brain functions, but its full role is not yet fully understood.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.